Price T Rowe Associates Inc Stereotaxis, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 76,199 shares of STXS stock, worth $148,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,199
Previous 58,400
30.48%
Holding current value
$148,588
Previous $153,000
9.15%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding STXS
# of Institutions
78Shares Held
41.1MCall Options Held
413KPut Options Held
26.3K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$26.7 Million6.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.95MShares$7.7 Million4.18% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$6.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.03MShares$5.91 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.78MShares$5.42 Million6.2% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $146M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...